4883 Modalis Therapeutics CorporationモダリスTSE Growth / Pharmaceuticals
0 posts
Modalis Therapeutics Corporation stock surged on Nov 18: what happened
It closed at ¥31.0 on Nov 18 (+¥3.0, +10.71%), ranking #18 among the top gainers of all stocks on the Tokyo Stock Exchange.
No disclosures were found for this stock around that day. Share what you know in the posts below.
Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.
Modalis Therapeutics Corporation (4883) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Modalis Therapeutics Corporation (4883) Stock Price History
Modalis Therapeutics Corporation closed at ¥28.0 on Nov 20, 2026, −12.5% over 1 month, −58.2% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥87,500 today (−12.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −12.5%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥28.0 | −2 | −6.67% |
| Nov 19 (Thu) | ¥30.0 | −1 | −3.23% |
| Nov 18 (Wed) | ¥31.0 | +3 | +10.71% |
| Nov 17 (Tue) | ¥28.0 | −1 | −3.45% |
| Nov 16 (Mon) | ¥29.0 | −1 | −3.33% |
| Nov 13 (Fri) | ¥30.0 | +3 | +11.11% |
| Nov 12 (Thu) | ¥27.0 | −2 | −6.90% |
| Nov 11 (Wed) | ¥29.0 | +0 | +0.00% |
| Nov 10 (Tue) | ¥29.0 | +3 | +11.54% |
| Nov 9 (Mon) | ¥26.0 | +2 | +8.33% |
If you had invested ¥100,000 3 months ago, it would be worth ¥84,848 today (−15.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −15.2%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥28.0 | −2 | −6.67% |
| Nov 19 (Thu) | ¥30.0 | −1 | −3.23% |
| Nov 18 (Wed) | ¥31.0 | +3 | +10.71% |
| Nov 17 (Tue) | ¥28.0 | −1 | −3.45% |
| Nov 16 (Mon) | ¥29.0 | −1 | −3.33% |
| Nov 13 (Fri) | ¥30.0 | +3 | +11.11% |
| Nov 12 (Thu) | ¥27.0 | −2 | −6.90% |
| Nov 11 (Wed) | ¥29.0 | +0 | +0.00% |
| Nov 10 (Tue) | ¥29.0 | +3 | +11.54% |
| Nov 9 (Mon) | ¥26.0 | +2 | +8.33% |
If you had invested ¥100,000 6 months ago, it would be worth ¥48,276 today (−51.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −51.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥28.0 | +0.0% |
| Oct 2026 | ¥28.0 | −9.7% |
| Sep 2026 | ¥31.0 | −8.8% |
| Aug 2026 | ¥34.0 | +13.3% |
| Jul 2026 | ¥30.0 | −9.1% |
| Jun 2026 | ¥33.0 | −26.7% |
| May 2026 | ¥45.0 | −43.8% |
If you had invested ¥100,000 1 year ago, it would be worth ¥41,791 today (−58.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −58.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥28.0 | +0.0% |
| Oct 2026 | ¥28.0 | −9.7% |
| Sep 2026 | ¥31.0 | −8.8% |
| Aug 2026 | ¥34.0 | +13.3% |
| Jul 2026 | ¥30.0 | −9.1% |
| Jun 2026 | ¥33.0 | −26.7% |
| May 2026 | ¥45.0 | −43.8% |
| Apr 2026 | ¥80.0 | +40.4% |
| Mar 2026 | ¥57.0 | −3.4% |
| Feb 2026 | ¥59.0 | −1.7% |
| Jan 2026 | ¥60.0 | +7.1% |
| Dec 2025 | ¥56.0 | −17.6% |
| Nov 2025 | ¥68.0 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥21,538 today (−78.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −78.5%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥28.0 | −50.0% |
| 2025 | ¥56.0 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥3,585 today (−96.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −96.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥28.0 | −50.0% |
| 2025 | ¥56.0 | ― |
If you had invested ¥100,000 in Aug 2020, it would be worth ¥1,167 today (−98.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +143.4%, while this stock moved −98.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥28.0 | −50.0% |
| 2025 | ¥56.0 | −45.1% |
| 2024 | ¥102 | −17.7% |
| 2023 | ¥124 | −63.0% |
| 2022 | ¥335 | −45.4% |
| 2021 | ¥613 | −72.3% |
| 2020 | ¥2,212 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Aug 2020). Please check the latest prices before trading.
Modalis Therapeutics Corporation (4883) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Modalis Therapeutics Corporation (4883)
Business overview
The company's main business is developing gene therapies for genetic diseases using its proprietary platform, "non-cutting CRISPR technology" (CRISPR-GNDM technology). Most of the genetic diseases it targets are rare diseases with few patients, and it notes that 95% of them still have no treatment. CRISPR-GNDM technology uses Cas9, the enzyme at the core of the CRISPR/Cas9 genome editing technology, to regulate gene activity without cutting DNA. It has a subsidiary in Massachusetts in the US. It operates a single gene therapy development segment.
Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 1.41x | Below the sector median of 1.86x (No. 24 from the lowest) |
|---|---|---|
| Market cap | ¥3.2 bn | No. 69 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥80 | 4/30 |
|---|---|---|
| 52-week low | ¥24 | 11/6 |
| Current position | 7.1% | Where the low is 0% and the high is 100% (close on 11/20: ¥28) |
| Year to date | -50.0% | No. 67 of 77 in the sector (best first) |
| 1 year | -58.2% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 4 times | Latest: 11/18 (No. 18) |
|---|---|---|
| Top 50 losers | 1 times | Latest: 10/21 (No. 7) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/18 16:40第三者割当により発行された第19回新株予約権(行使価額修正条項付)の大量行使、行使の完了及び月間行使状況に関するお知らせ
- 11/12 15:302026年12月期 第3四半期決算短信〔日本基準〕(連結)
- 11/12 15:30第三者割当により発行された第19回新株予約権(行使価額修正条項付)の行使停止指定に関するお知らせ
- 11/12 15:30営業外収益(為替差益)の計上に関するお知らせ
- 11/12 15:302026年12月期 第3四半期決算説明資料
- 11/02 15:30第三者割当により発行された第19回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ
- 10/01 12:20第三者割当により発行された第19回新株予約権(行使価額修正条項付)の 大量行使及び月間行使状況に関するお知らせ
- 09/10 17:00第三者割当により発行された第19回新株予約権(行使価額修正条項付)の大量行使に関するお知らせ
Filings from the past 12 months (8).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Modalis Therapeutics Corporation board
More Japanese stocks in English
- Kringle Pharma,Inc.4884
- MUROMACHI CHEMICALS INC.4885
- ASKA Pharmaceutical Holdings Co.,Ltd.4886
- SAWAI GROUP HOLDINGS Co.,Ltd.4887
- STELLA PHARMA CORPORATION4888
- Renascience Inc.4889
- iShares Yen Appreciation Focus ETF488A
- Tsubota Laboratory Incorporated4890
- TMS Co.,Ltd.4891
- Cyfuse Biomedical K.K.4892
- Noile-Immune Biotech Inc.4893
- Cuorips Inc.4894